KEGG   DRUG: ErlizumabHelp
Entry
D04045                      Drug                                   

Name
Erlizumab (USAN/INN)
Activity
Immunosuppressant, Anti-CD18 antibody
Comment
Adjunctive treatment to reperfusion therapy in acute myocardial infarction or other types of reperfusion therapy
Monoclonal antibody
Target
  Pathway
Cytokine-cytokine receptor interaction
Cell adhesion molecules (CAMs)
Brite
Target-based classification of drugs [BR:br08310]
 Cytokine receptors
  TNF receptor family
   LTBR (CD18)
    Erlizumab
     D04045  Erlizumab (USAN/INN)
 Others
  Cellular antigens
   CD11a
    Erlizumab
     D04045  Erlizumab (USAN/INN)
BRITE hierarchy
Other DBs
CAS: 
211323-03-4
PubChem: 

» Japanese version   » Back

DBGET integrated database retrieval system